
Robert L. Gottlieb
Advanced Heart Failure and Transplant Cardiology
3410 Worth St
Ste 250
Dallas, TX 75246
Ste 250
Dallas, TX 75246
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
A pilot randomized controlled trial protocol of overground robotic exoskeleton-assisted early ambulation after cardiovascular and thoracic surgery in the acute care setting (REACT-CVTS).
Journal: Proceedings (Baylor University. Medical Center)
Published: July 15, 2026
INSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis Cardiomyopathy.
Journal: JACC. Advances
Published: April 20, 2026
Real-world effectiveness of remdesivir in immunocompromised patients hospitalized due to SARS-CoV-2 Infection: Insights to inform pharmacy practice.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: February 10, 2026
Lower mortality risk associated with remdesivir plus corticosteroids vs corticosteroids alone for the treatment of patients hospitalized with SARS-CoV-2 infection in the early and later Omicron periods.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: February 09, 2026
Fluid Management of Acute Heart Failure With the Reprieve System: The Randomized Controlled FASTR Trial.
Journal: JACC. Heart failure
Published: February 09, 2026
Clarity in ex-vivo cardiac transport system naming conventions.
Journal: JHLT open
Published: February 04, 2026
ARNI Over ACEI Lacks Clinical Benefit in Patients With Chagas Cardiomyopathy.
Journal: JAMA
Published: December 03, 2025
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination.
Journal: JAMA network open
Published: April 01, 2025
Exercise capacity and cardiac allograft ischemic time in recent heart transplant recipients.
Journal: JHLT open
Published: March 27, 2025
Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19.
Journal: Scientific reports
Published: January 28, 2025
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.
Journal: The Lancet. Infectious diseases
Published: December 20, 2024
Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 15, 2024
Last Updated: 09/26/2026